Protesters Target GSK Over HIV Drug Patent

Law360 (August 7, 2006, 12:00 AM EDT) -- Protests have erupted in Thailand as its government prepares to grant a patent to British drug maker GlaxoSmithKline for a popular HIV treatment, despite the fact that an appeal over patentability hasn’t yet been ruled on.

Hundreds of Thai demonstrators, many of them living with HIV/AIDS, staged a noisy protest at GSK’s headquarters in Bangkok, arguing that an increase in the cost of the anti-retroviral will threaten lives.

In the world of generic drugs, such arguments are hardly new. But the activists’ complaints have transcended moral...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.